This trial will test how a special light treatment can help Multiple Myeloma patients with their sleep, inflammation and symptoms. 200 people will receive this light over a 2-month period.
- Multiple Myeloma
1 Primary · 29 Secondary · Reporting Duration: at 3 days following engraftment
2 Treatment Groups
Circadian Effective Lighting (CEL)
1 of 2
Circadian Ineffective Lighting (CIL)
1 of 2
200 Total Participants · 2 Treatment Groups
Primary Treatment: Circadian Effective Lighting (CEL) · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
How many prior treatments have patients received?
What state do they live in?
Frequently Asked Questions
Are researchers still accepting participants for this experiment?
"Affirmative. According to the information on clinicaltrials.gov, this medical experiment is actively recruiting participants after its initial posting on February 1st 2023 and most recent edit of February 10th 2023. Two hundred patients need to be recruited from two different sites for this trial." - Anonymous Online Contributor
How many individuals are being recruited to partake in this investigation?
"Indeed, the data on clinicaltrials.gov verifies that this trial is actively recruiting participants. This medical investigation was initially presented to the public on February 1st 2023 and has been updated as recently as February 10th 2023. The research team aims to include 200 subjects from 2 different sites in their study." - Anonymous Online Contributor